Table 1.
Author, year, (Ref.) | Number of patients, study design | Age of thrombosis | Grade of PVT partial/occlusive/cavernoma** (n) | Resolution of PVT partial/complete/any (%) |
---|---|---|---|---|
Van Ha, 2006[22] | 15, retrospective | Acute 11 Chronic 4 | 7/8/4 | n.d.∗/n.d.*/77 |
Bauer, 2006[23] | 9, retrospective | Chronic 9 | 0/9/4 | 11/56/67 |
Senzolo, 2006[11] | 13, retrospective | 5.5 months (0.5–24) | 5/8/3 | n.d.* |
Perarnau, 2010[24] | 123, retrospective | Acute 15 Chronic 108 | 94/29/14 | n.d.* |
Han, 2011[25] | 57, retrospective | Acute 0 Chronic 57 | 35/22/30 | n.d.*/n.d.*/100*** |
Luca, 2011[10] | 70, prospective | 4.7 months (0–66) | 46/24/2 | 30/57/87 |
Senzolo, 2012[13] | 7, prospective | n.d.* | n.d.* | 67/33/100*** |
Avola, 2012[20] | 15, retrospective | Chronic 15 | 15/0/0 | 0/100/100 |
Salem, 2015[12] | 44, retrospective | Chronic 44 | 0/44/13 | 16/74/90 |
Luo, 2015[26]§ | 37, prospective | Chronic 37 | 24/13/0 | 13/52/65 |
Zhao, 2016[27] | 191, retrospective | n.d.* | 143/48/? | 31/69/100*** |
Lv, 2017[28] | 212, retrospective | Acute 17 Chronic 195 | 150/62/47 | n.d.* |
Lv, 2017[29] § | 24, randomized | Acute 2 Chronic 22 | 16/8/11 | 9/86/95 |
Patients with a cavernoma are a subgroup of patients with occlusive thrombosis;
n.d.: no sufficient data;
Only for patients with successful TIPS intervention;
randomized study, TIPS versus medical treatment (banding ligation and propranolol). All patients received Vit K antagonists. TIPS: transjugular intrahepatic portosystemic shunt; PVT: portal vein thrombosis.